Cooper Companies | COO - 当期純利益





当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Align Technology USD 112.77M 22.99M 2026-03
AtriCure USD 108K 1.65M 2026-03
Avanos Medical USD 5.1M 6.4M 2026-03
Bausch Health Companies USD -1.42B 1.31B 2026-03
Baxter International USD -15M 1.11B 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD -77.9M 208.7M 2026-03
Dentsply International USD -10M 136M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.24B 100M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Novartis USD 2.41B 1.52B 2025-12
ResMed USD 398.73M 6.14M 2026-03
STAAR Surgical USD 5.21M 23.52M 2026-03
Steris USD 220.3M 27.4M 2026-03
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -8.15M 706.18M 2026-03
Utah Medical Products USD 2.57M 445K 2025-12
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03